SCALAMBRINO, ERICA
SCALAMBRINO, ERICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia
2026 N. Bitto, G. Tosetti, A. Tripodi, A. Lecchi, S. La Marca, L. Padovan, E. Scalambrino, M. Clerici, C. Caputo, M. Lucà, M. Primignani, A.L. Fracanzani, P. Lampertico, F. Peyvandi, V. La Mura
Impact of blood centrifugation on the parameters of thrombin generation assay revisited to look for possible revision of the current guidance
2025 E. Scalambrino, M. Clerici, F. Peyvandi, A. Tripodi
Thrombin Generation Assays: What are the Current Clinical Applications?
2025 A. Tripodi, M. Clerici, E. Scalambrino, F. Peyvandi
Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry
2025 A. Tripodi, M. Clerici, E. Scalambrino, S. Arcudi, R. Gualtierotti, C. Novembrino, F. Peyvandi
D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation
2024 A. Tripodi, M. Capecchi, E. Scalambrino, M. Clerici, B. Scimeca, P. Agosti, P. Bucciarelli, F. Peyvandi
Comparative Investigation of Thromboelastometry and Thrombin Generation for Patients Receiving Direct Oral Anticoagulants or Vitamin K Antagonists
2024 A. Tripodi, M. Capecchi, E. Scalambrino, M. Clerici, B. Scimeca, P. Agosti, P. Bucciarelli, A. Artoni, F. Peyvandi
COVID-19. Comparison of D-dimer levels measured with 3 commercial platforms
2023 E. Scalambrino, M. Clerici, S. Scardo, M. Capecchi, C. Della Noce, S. Testa, F. Peyvandi, A. Tripodi
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
2023 M. Capecchi, P. De Leo, M. Abbattista, I. Mancini, P. Agosti, M. Biganzoli, C. Suffritti, B. Ferrari, A. Lecchi, S. La Marca, L. Padovan, E. Scalambrino, M. Clerici, A. Tripodi, A. Artoni, R. Gualtierotti, F. Peyvandi
Bilirubin color interference on prothrombin time and activated partial thromboplastin time tests assessed in patients with liver disease
2023 E. Scalambrino, E.M. Faioni, M. Clerici, I. Avarello, M. Capecchi, S. Pasca, A. Tripodi
Thromboplastin calibration revisited to look for possible revision of the World Health Organization recommendations
2023 A. Tripodi, E. Scalambrino, M. Clerici, V. Chantarangkul, F. Peyvandi
Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
2023 A. Tripodi, E. Scalambrino, M. Clerici, F. Peyvandi
Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
2022 L. Valenti, A. Tripodi, V. La Mura, S. Pelusi, C. Bianco, E. Scalambrino, S. Margarita, F. Malvestiti, L. Ronzoni, M. Clerici, R. D'Ambrosio, M. Fraquelli, R. Carpani, D. Prati, F. Peyvandi
Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study
2021 S.M. Passamonti, A. Artoni, G. Carrabba, G. Merati, M. Abbattista, M. Capecchi, M. Castellani, C. Marenghi, E. Trombetta, L. Giammattei, M. Caroli, P. Bucciarelli, E. Scalambrino, F. Peyvandi, I. Martinelli
Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge
2021 A. Tripodi, S.C. Rossi, M. Clerici, G. Merati, E. Scalambrino, I. Mancini, L. Baronciani, M. Boscarino, V. Monzani, F. Peyvandi
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study
2021 S. Ghirardello, A. Lecchi, A. Artoni, M. Panigada, S. Aliberti, E. Scalambrino, S. La Marca, M. Boscarino, A. Gramegna, P. Properzi, C. Abruzzese, F. Blasi, G. Grasselli, F. Mosca, A. Tripodi, F. Peyvandi
Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection
2021 A. Tripodi, E. Scalambrino, V. Chantarangkul, O. Paoletti, M. Clerici, C. Novembrino, M. Boscolo-Anzoletti, F. Peyvandi, S. Testa
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels
2021 M. Capecchi, E. Scalambrino, S. Griffini, E. Grovetti, M. Clerici, G. Merati, V. Chantarangkul, M. Cugno, F. Peyvandi, A. Tripodi
No changes of parameters nor coagulation activation in healthy subjects vaccinated for {SARS}-Cov-2
2021 F. Payvandi, E. Scalambrino, M. Clerici, A. Lecchi, N. Revelli, R. Palla, R. Gualtierotti, D. Prati, A. Tripodi
Procoagulant imbalance in Klinefelter syndrome assessed by thrombin generation assay and whole blood thromboelastometry
2021 R. Indirli, E. Ferrante, E. Scalambrino, E. Profka, M. Clerici, T. Lettera, A.L. Serban, W. Vena, A. Pizzocaro, M. Bonomi, B. Cangiano, G. Carosi, G. Mazziotti, L. Persani, A. Lania, M. Arosio, F. Peyvandi, G. Mantovani, A. Tripodi
Effect of emicizumab on global coagulation assays for plasma supplemented with apixaban or argatroban
2020 A. Tripodi, V. Chantarangkul, L. Padovan, M. Clerici, E. Scalambrino, F. Peyvandi